Top Markets
Coin of the day
INOVIQ Ltd INOVIQ Ltd

INOVIQ Ltd

IIQ
Pozycja w akcjach #29957
INOVIQ Ltd specializes in the research, development, and commercialization of... INOVIQ Ltd specializes in the research, development, and commercialization of diagnostic and exosome-based products, aiming to improve the detection and treatment of cancer and other conditions across Australia and the United States. Its current portfolio includes the hTERT test, an immunocytochemistry assay that serves as a supplementary tool for urine cytology in bladder cancer screening, alongside EXO-NET, designed for the capture and isolation of exosomes from liquid biopsy specimens. The company also boasts a robust diagnostic pipeline, featuring blood tests currently under development for various cancers, including ovarian and breast cancer. Originally incorporated in 1983 and formerly known as BARD1 Life Sciences Limited until its rebranding to INOVIQ Ltd in December 2021, the company maintains its headquarters in Notting Hill, Australia.
Cena akcji
$0.13400411
Kapitalizacja rynkowa
$18.86M
Zmiana (1 dzień)
2.70%
Zmiana (1 rok)
-48.10%
Kraj
AU
Handel INOVIQ Ltd (IIQ)

Kategoria

Historia ceny akcji dla INOVIQ Ltd (IIQ)
Najwyższa cena zamknięcia: $0.14 dnia 2026-08-01

Najniższa cena zamknięcia: $166.60 dnia 1988-01-01
Historia cen akcji firmy INOVIQ Ltd od 1988 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 1.45%
2025 -30.46%
2024 -24.16%
2023 -0.02%
2022 -43.77%
2021 47.46%
2020 -21.25%
2019 50.59%
2018 181.83%
2017 -75.39%
2016 1.49%
2015 -12.13%
2014 16.04%
2013 -70.72%
2012 -55.14%
2011 -15.17%
2010 21.81%
2009 212.35%
2008 -62.47%
2007 -25.96%
2006 -63.96%
2005 -46.59%
2004 79.49%
2003 90.17%
2002 26.00%
2001 -70.94%
2000 -51.79%
1999 -19.50%
1998 26.20%
1997 -22.09%
1996 77.59%
1995 -11.75%
1994 -13.96%
1993 107.22%
1992 31.18%
1991 187.46%
1990 -83.26%
1989 -66.96%
1988 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$591.22 18.65%
US
$200.34 -5.59%
US
$23.61 87.85%
CN
$312.51 95.17%
US
$557.21 -12.49%
US